Sex Differences in the Treatment of HIV

Current HIV/AIDS Reports
Jennifer CohnCatherine Godfrey

Abstract

Biological and societal influences are different for men and women leading to different HIV outcomes and related infectious and non-infectious complications. This review evaluates sex differences in the epidemiology and immunological response to HIV and looks at major complications and coinfections, as well as care delivery systems focusing on low- and middle-income countries (LMICs) where most people with HIV live. More women than men access testing and treatment services in LMIC; women are more likely to be virologically suppressed in that environment. There is a growing recognition that the enhanced immunological response to several pathogens including HIV may result in improved outcomes for infectious comorbidities but may result in a greater burden of non-communicable diseases. Men and women have different requirements for HIV care. Attention to these differences may improve outcomes for all.

References

Aug 1, 1990·The American Review of Respiratory Disease·Y YamamotoT Setogawa
Sep 2, 2000·Journal of Acquired Immune Deficiency Syndromes : JAIDS·K AnastosR M Greenblatt
Mar 10, 2001·The New England Journal of Medicine·T R SterlingT C Quinn
Aug 31, 2002·The American Journal of Tropical Medicine and Hygiene·Thomas P MonathPhilip Bedford
Mar 3, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stephen D LawnRobin Wood
Apr 26, 2007·The Journal of Clinical Endocrinology and Metabolism·Virginia A TriantSteven K Grinspoon
Apr 27, 2007·The New England Journal of Medicine·UNKNOWN DAD Study GroupJens D Lundgren
May 23, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Niels ObelJan Gerstoft
Aug 21, 2007·Gender Medicine·Ighovwerha OfotokunJane E Hitti
Aug 30, 2008·Nature Reviews. Immunology·Eleanor N Fish
Oct 24, 2008·PLoS Medicine·Lewis H KullerUNKNOWN INSIGHT SMART Study Group
Dec 23, 2009·PLoS Medicine·Olivier Neyrolles, Lluis Quintana-Murci
Apr 20, 2010·AIDS·Sylvie LangUNKNOWN French Hospital Database on HIV-ANRS CO4
Jan 15, 2011·Journal of Clinical Pharmacology·Obi C UmehCourtney V Fletcher
Jan 20, 2011·The Journal of Infectious Diseases·Amie L MeditzElizabeth Connick
Jan 22, 2011·The Journal of Infectious Diseases·Netanya G SandlerUNKNOWN INSIGHT SMART Study Group
Apr 15, 2011·AIDS Research and Treatment·Roos E BarthAndy I M Hoepelman
Jun 8, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jennifer L LyonsDana Gabuzda
Sep 29, 2011·Journal of the International Association of Physicians in AIDS Care : JIAPAC·Mhairi MaskewMatthew P Fox
Oct 18, 2011·Emerging Infectious Diseases·Stephen J Seligman
Nov 1, 2011·The Lancet Infectious Diseases·Raph L HamersUNKNOWN PharmAccess African Studies to Evaluate Resistance (PASER) Investigators
Nov 10, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Gilles WandelerUNKNOWN SolidarMed ART program and IeDEA-Southern Africa
May 15, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Felicia C ChowVirginia A Triant
Sep 13, 2012·PloS One·Daniel A DuprezUNKNOWN INSIGHT SMART Study Group
Sep 14, 2012·PLoS Medicine·Morna CornellUNKNOWN International Epidemiologic Databases to Evaluate AIDS Southern Africa Collaboration
Sep 18, 2013·The Journal of Infectious Diseases·Kathleen V FitchSteven K Grinspoon
Oct 16, 2013·European Heart Journal·Friedrich ThienemannJürgen Kurt Rockstroh
Dec 25, 2013·Proceedings of the National Academy of Sciences of the United States of America·David FurmanMark M Davis
Mar 4, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Marcelo ChenYi-Ming Arthur Chen
Mar 15, 2014·PloS One·Alvaro H BorgesUNKNOWN SILCAAT Scientific Committee

❮ Previous
Next ❯

Citations

Dec 6, 2020·Current Opinion in HIV and AIDS·Eileen P Scully
Mar 16, 2021·Current HIV/AIDS Reports·Marta Rodriguez-GarciaMimi Ghosh
Jun 19, 2021·HIV Research & Clinical Practice·Elizabeth BarrSusan E Cohn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved